IOVA logo

Iovance Biotherapeutics (IOVA)

Profile

Full Name

Iovance Biotherapeutics, Inc.

Ticker Symbol

IOVA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 15, 2010

Indexes

Not included

Website

http://www.iovance.com

Employees

838

Key Details

Price

$1.69(-2.87%)

Market cap

$564.35M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$164.07M(+13698.99% YoY)

Annual EPS

-$1.28(+32.28% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.69
    IOVA price is $1.69

    30-Day Relative Volume

    1.08
    IOVA 30-day relative volume is 1.08

    Price Performance

    Price Most recent change

    -2.87%
    IOVA price was down -2.87% on Jun 27, 2025

    Price YTD change

    -77.16%
    IOVA price is down -77.16% since January 1st

    Price 1-year change

    -78.9%
    IOVA price is down -78.9% year-on-year

    Price 3-year change

    -84.82%
    IOVA price is down -84.82% over the past 3 years

    Price Range

    Price All-time high

    $165.00
    IOVA price is currently -98.98% below its historical high of $165.00

    Price 3-year low

    $1.64
    IOVA price is currently +3.05% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $564.35M
    IOVA market capitalization is $564.35 million

    Market cap 3-year change

    -67.74%
    IOVA market capitalization is down -67.74% over the past 3 years

    Market cap All-time high

    $7.72B
    IOVA market capitalization is currently -92.69% below its historical high of $7.72 billion

    Market cap sector rank

    69.15%
    IOVA market capitalization is higher than 69.15% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +19.33%
    IOVA shares outstanding is up +19.33% year-on-year

    Shares Outstanding 3-Year Change

    +112.47%
    IOVA shares outstanding is up +112.47% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.60
    IOVA beta is 1.60

    200-day SMA

    $6.00
    IOVA price is currently -71.86% below its 200-day simple moving average

    50-day SMA

    $2.35
    IOVA price is currently -28.00% below its 50-day simple moving average

    RSI

    35.58
    IOVA 14-day relative strength index is 35.58

    Volume

    1.08
    IOVA 30-day relative volume is 1.08

    ATR

    $0.15
    IOVA average true range is $0.15

    10-day Historical Volatility

    45.25%
    IOVA 10-day historical volatility is 45.25%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $164.07M
    IOVA annual revenue is $164.07 million

    Revenue Analysts estimate

    $287.11M
    IOVA annual revenue is currently -42.85% lower than the consensus analysts' forecast

    Revenue 1-year change

    +13698.99%
    IOVA annual revenue is up +13698.99% year-on-year

    Revenue Sector rank

    61.13%
    IOVA annual revenue is higher than 61.13% of companies in Healthcare sector

    EPS

    EPS

    -$1.28
    IOVA annual earnings per share is -$1.28

    EPS Analysts estimate

    -$1.06
    IOVA annual earnings per share is currently +21.17% higher than the consensus analysts' forecast

    EPS 1-year change

    +32.28%
    IOVA annual earnings per share is up +32.28% year-on-year

    EPS Sector rank

    49.67%
    IOVA annual earnings per share is higher than 49.67% of companies in Healthcare sector

    Profit

    Gross profit

    $40.08M
    IOVA annual gross profit is $40.08 million

    Gross margin

    24.43%
    IOVA annual gross profit margin is 24.43%

    Operating profit

    -$395.28M
    IOVA annual operating income is -$395.28 million

    Operating margin

    -240.92%
    IOVA annual operating profit margin is -240.92%

    Net income

    -$372.18M
    IOVA annual net profit is -$372.18 million

    Net margin

    -226.84%
    IOVA annual net profit margin is -226.84%

    Expenses

    Total expenses

    $559.35M
    IOVA annual total expenses is $559.35 million

    Operating expenses

    $435.35M
    IOVA annual total operating expenses is $435.35 million

    Cost of goods sold

    $124.00M
    IOVA annual cost of goods sold is $124.00 million

    Selling, general & administrative expenses

    $153.02M
    IOVA annual SGA is $153.02 million

    Depreciation and amortization

    $43.61M
    IOVA annual depreciation & amortization is $43.61 million

    Interest expense

    -
    IOVA annual interest expense value is unknown

    Income tax

    -$2.83M
    IOVA annual income tax is -$2.83 million

    EBIT & EBITDA

    EBIT

    -$395.28M
    IOVA annual earnings before interest & taxes is -$395.28 million

    EBITDA

    -$351.67M
    IOVA annual EBITDA is -$351.67 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $910.43M
    IOVA annual total assets is $910.43 million

    Non current assets

    $453.41M
    IOVA annual long term assets is $453.41 million

    Current assets

    $457.02M
    IOVA annual total current assets is $457.02 million

    Cash and cash equivalents

    $115.69M
    IOVA annual cash & cash equivalents is $115.69 million

    Accounts receivable

    $69.34M
    IOVA annual accounts receivable is $69.34 million

    Inventory

    $51.52M
    IOVA annual inventory is $51.52 million

    Liabilities

    Total liabilities

    $200.02M
    IOVA annual total liabilities is $200.02 million

    Long term liabilities

    $77.68M
    IOVA annual total long term liabilities is $77.68 million

    Current liabilities

    $122.34M
    IOVA annual total current liabilities is $122.34 million

    Accounts payable

    $27.51M
    IOVA annual accounts payable is $27.51 million

    Debt

    Total debt

    $58.26M
    IOVA annual total debt is $58.26 million

    Total debt 1-year change

    -23.2%
    IOVA annual total debt is down -23.2% year-on-year

    Long term debt

    $45.37M
    IOVA annual long term debt is $45.37 million

    Short term debt

    $12.90M
    IOVA annual short term debt is $12.90 million

    Equity & Capital

    Shareholders equity

    $710.40M
    IOVA annual stockholders equity is $710.40 million

    Book value

    $710.40M
    IOVA annual book value is $710.40 million

    Retained earnings

    -$2.38B
    IOVA annual retained earnings is -$2.38 billion

    Working capital

    $334.68M
    IOVA annual working capital is $334.68 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$352.98M
    IOVA annual cash flow from operations is -$352.98 million

    Cash from operations 1-year change

    +2.44%
    IOVA annual cash flow from operations is up +2.44% year-on-year

    Cash from investing

    -$96.41M
    IOVA annual cash flow from investing activities is -$96.41 million

    Cash from investing 1-year change

    +37.9%
    IOVA annual cash flow from investing activities is up +37.9% year-on-year

    Cash from financing

    $390.66M
    IOVA annual cash flow from financing activities is $390.66 million

    Cash from financing 1-year change

    -15.62%
    IOVA annual cash flow from financing activities is down -15.62% year-on-year

    CAPEX

    CAPEX

    $11.07M
    IOVA annual capital expenditures is $11.07 million

    CAPEX 1-year change

    -50.34%
    IOVA annual capital expenditures is down -50.34% year-on-year

    Free Cash Flow

    Free cash flow

    -$364.05M
    IOVA annual free cash flow is -$364.05 million

    Free cash flow 1-year change

    +5.22%
    IOVA annual free cash flow is up +5.22% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    24.43%
    IOVA annual gross profit margin is 24.43%

    Operating margin

    -240.92%
    IOVA annual operating profit margin is -240.92%

    Net margin

    -226.84%
    IOVA annual net profit margin is -226.84%

    ROA & ROE

    ROA

    -44.02%
    IOVA annual return on assets is -44.02%

    ROE

    -57.48%
    IOVA annual return on equity is -57.48%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    IOVA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    IOVA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.73
    IOVA price to book ratio is 0.73

    PB ratio Sector rank

    34.4%
    IOVA price to book ratio is higher than 34.4% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.65
    IOVA price to sales ratio is 2.65

    PS ratio Sector rank

    48.48%
    IOVA price to sales ratio is higher than 48.48% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $446.40M
    IOVA enterprise value is $446.40 million

    Enterprise value Sector rank

    65.62%
    IOVA enterprise value is higher than 65.62% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.26
    IOVA EV/EBITDA is -1.26

    EV/EBITDA Sector rank

    43.6%
    IOVA EV/EBITDA is higher than 43.6% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.74
    IOVA annual current ratio is 3.74

    Quick ratio

    3.31
    IOVA annual quick ratio is 3.31

    Leverage

    Debt to equity

    0.00
    IOVA annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    IOVA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    4
    IOVA piotroski f-score is 4

    Altman Z-Score

    -2.79
    IOVA altman z-score is -2.79

    Analyst ratings

    Recent major analysts updates

    May 16, 25 UBS
    Neutral
    May 12, 25 Mizuho
    Outperform
    May 12, 25 Goldman Sachs
    Buy
    May 12, 25 Barclays
    Overweight
    May 9, 25 JMP Securities
    Market Perform
    May 9, 25 HC Wainwright & Co.
    Buy
    May 9, 25 Chardan Capital
    Buy
    Apr 17, 25 Goldman Sachs
    Buy
    Apr 14, 25 Barclays
    Overweight
    Mar 3, 25 Truist Securities
    Buy

    Institutional Ownership

    Screeners with IOVA included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Iovance Biotherapeutics?
    • Does Iovance Biotherapeutics pay dividends?
    • What sector is Iovance Biotherapeutics in?
    • What industry is Iovance Biotherapeutics in?
    • What country is Iovance Biotherapeutics based in?
    • When did Iovance Biotherapeutics go public?
    • Is Iovance Biotherapeutics in the S&P 500?
    • Is Iovance Biotherapeutics in the NASDAQ 100?
    • Is Iovance Biotherapeutics in the Dow Jones?
    • When was Iovance Biotherapeutics's last earnings report?
    • When does Iovance Biotherapeutics report earnings?
    • Should I buy Iovance Biotherapeutics stock now?

    What is the ticker symbol for Iovance Biotherapeutics?

    The ticker symbol for Iovance Biotherapeutics is NASDAQ:IOVA

    Does Iovance Biotherapeutics pay dividends?

    No, Iovance Biotherapeutics does not pay dividends

    What sector is Iovance Biotherapeutics in?

    Iovance Biotherapeutics is in the Healthcare sector

    What industry is Iovance Biotherapeutics in?

    Iovance Biotherapeutics is in the Biotechnology industry

    What country is Iovance Biotherapeutics based in?

    Iovance Biotherapeutics is headquartered in United States

    When did Iovance Biotherapeutics go public?

    Iovance Biotherapeutics's initial public offering (IPO) was on October 15, 2010

    Is Iovance Biotherapeutics in the S&P 500?

    No, Iovance Biotherapeutics is not included in the S&P 500 index

    Is Iovance Biotherapeutics in the NASDAQ 100?

    No, Iovance Biotherapeutics is not included in the NASDAQ 100 index

    Is Iovance Biotherapeutics in the Dow Jones?

    No, Iovance Biotherapeutics is not included in the Dow Jones index

    When was Iovance Biotherapeutics's last earnings report?

    Iovance Biotherapeutics's most recent earnings report was on May 8, 2025

    When does Iovance Biotherapeutics report earnings?

    The next expected earnings date for Iovance Biotherapeutics is Aug 8, 2025

    Should I buy Iovance Biotherapeutics stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page